The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The Major Green Tea Polyphenol, (-)-Epigallocatechin-3-Gallate, Inhibits Obesity, Metabolic Syndrome, and Fatty Liver Disease in High-Fat–Fed Mice
Open accessAbstract
In this study, we investigated the effects of the major green tea polyphenol, (−)-epigallocatechin-3-gallate (EGCG), on high-fat–induced obesity, symptoms of the metabolic syndrome, and fatty liver in mice. In mice fed a high-fat diet (60% energy as fat), supplementation with dietary EGCG treatment (3.2 g/kg diet) for 16 wk reduced body weight (BW) gain, percent body fat, and visceral fat weight (P < 0.05) compared with mice without EGCG treatment. The BW decrease was associated with increased fecal lipids in the high-fat–fed groups (r2 = 0.521; P < 0.05). EGCG treatment attenuated insulin resistance, plasma cholesterol, and monocyte chemoattractant protein concentrations in high-fat–fed mice (P < 0.05). EGCG treatment also decreased liver weight, liver triglycerides, and plasma alanine aminotransferase concentrations in high-fat–fed mice (P < 0.05). Histological analyses of liver samples revealed decreased lipid accumulation in hepatocytes in mice treated with EGCG compared with high-fat diet-fed mice without EGCG treatment. In another experiment, 3-mo-old high-fat–induced obese mice receiving short-term EGCG treatment (3.2 g/kg diet, 4 wk) had decreased mesenteric fat weight and blood glucose compared with high-fat–fed control mice (P < 0.05). Our results indicate that long-term EGCG treatment attenuated the development of obesity, symptoms associated with the metabolic syndrome, and fatty liver. Short-term EGCG treatment appeared to reverse preexisting high-fat–induced metabolic pathologies in obese mice. These effects may be mediated by decreased lipid absorption, decreased inflammation, and other mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
Farrell, G. C., & Larter, C. Z. (2006) · Hepatology · doi:10.1002/hep.20973 · Cited by 2,414
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · cited 2×
“These effects may be mediated through the activation of protein kinase C, which is stimulated by fatty acids and contributes to the phosphorylation of the insulin receptor substrate at Ser-307, resulting in inhibition of normal insulin signaling (32,33).”
BackgroundDandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., & Garg, R. (2005) · Circulation · doi:10.1161/01.cir.0000158483.13093.9d · Cited by 1,263
Dulloo, A. G., Duret, C., Rohrer, D., Girardier, L., Mensi, N., Fathi, M., Chantre, P., & Vandermander, J. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.6.1040 · Cited by 924
The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease
Utzschneider, K. M., & Kahn, S. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0587 · Cited by 856
Morino, K., Petersen, K. F., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/db06-s002 · Cited by 853 · cited 1×
“These effects may be mediated through the activation of protein kinase C, which is stimulated by fatty acids and contributes to the phosphorylation of the insulin receptor substrate at Ser-307, resulting in inhibition of normal insulin signaling (32,33).”
BackgroundMurase, T., Nagasawa, A., Suzuki, J., Hase, T., & Tokimitsu, I. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802141 · Cited by 510
Mechanisms of Cancer Prevention by Tea Constituents
Lambert, J. D., & Yang, C. S. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.10.3262s · Cited by 490
Self-citationEpigallocatechin Gallate, a Constituent of Green Tea, Represses Hepatic Glucose Production
Waltner-Law, M. E., Wang, X. L., Law, B. K., Hall, R. K., Nawano, M., & Granner, D. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204672200 · Cited by 487
Nagao, T., Komine, Y., Soga, S., Meguro, S., Hase, T., Tanaka, Y., & Tokimitsu, I. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.122 · Cited by 467
Anti‐obesity effects of green tea: From bedside to bench
Wolfram, S., Wang, Y., & Thielecke, F. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500102 · Cited by 433
Klaus, S., Pültz, S., Thöne-Reineke, C., & Wolfram, S. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802926 · Cited by 423
Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases
Imai, K., & Nakachi, K. (1995) · BMJ · doi:10.1136/bmj.310.6981.693 · Cited by 410
Effect of EGCG on lipid absorption and plasma lipid levels in rats
Raederstorff, D. G., Schlachter, M. F., Elste, V., & Weber, P. (2003) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(03)00054-8 · Cited by 396
Potenza, M. A., Marasciulo, F. L., Tarquinio, M., Tiravanti, E., Colantuono, G., Federici, A., Kim, J.-A., Quon, M. J., & Montagnani, M. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00698.2006 · Cited by 380
Epigallocatechin Gallate Supplementation Alleviates Diabetes in Rodents
Wolfram, S., Raederstorff, D., Preller, M., Wang, Y., Teixeira, S. R., Riegger, C., & Weber, P. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.10.2512 · Cited by 331
Tsuneki, H., Ishizuka, M., Terasawa, M., Wu, J.-B., Sasaoka, T., & Kimura, I. (2004) · BMC Pharmacology · doi:10.1186/1471-2210-4-18 · Cited by 311
Molecular mechanisms of insulin resistance and associated diseases
Mlinar, B., Marc, J., Janež, A., & Pfeifer, M. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.07.005 · Cited by 301
Obesity: the disease of the twenty-first century
Rössner, S. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802209 · Cited by 278
Effects of green tea on weight maintenance after body-weight loss
Kovacs, E. M. R., Lejeune, M. P. G. M., Nijs, I., & Westerterp-Plantenga, M. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041061 · Cited by 235
Wu, L.-Y., Juan, C.-C., Hwang, L. S., Hsu, Y.-P., Ho, P.-H., & Ho, L.-T. (2004) · European Journal of Nutrition · doi:10.1007/s00394-004-0450-x · Cited by 204
Wolfram, S., Raederstorff, D., Wang, Y., Teixeira, S. R., Elste, V., & Weber, P. (2005) · Annals of Nutrition and Metabolism · doi:10.1159/000084178 · Cited by 202
Oolong Tea Increases Metabolic Rate and Fat Oxidation in Men
Rumpler, W., Seale, J., Clevidence, B., Judd, J., Wiley, E., Yamamoto, S., Komatsu, T., Sawaki, T., Ishikura, Y., & Hosoda, K. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.2848 · Cited by 199
Yu, R., Kim, C., Kwon, B., & Kawada, T. (2006) · Obesity · doi:10.1038/oby.2006.153 · Cited by 179
Bruno, R. S., Dugan, C. E., Smyth, J. A., DiNatale, D. A., & Koo, S. I. (2008) · The Journal of Nutrition · doi:10.1093/jn/138.2.323 · Cited by 176
Antihyperglycemic Effect of Oolong Tea in Type 2 Diabetes
Hosoda, K., Wang, M.-F., Liao, M.-L., Chuang, C.-K., Iha, M., Clevidence, B., & Yamamoto, S. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1714 · Cited by 163
Prevention and Treatment of the Metabolic Syndrome
Daskalopoulou, S. S., Mikhailidis, D. P., & Elisaf, M. (2004) · Angiology · doi:10.1177/00033197040550i601 · Cited by 157
Steptoe, A., Gibson, E. L., Vuononvirta, R., Hamer, M., Wardle, J., Rycroft, J. A., Martin, J. F., & Erusalimsky, J. D. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.054 · Cited by 125
Park, H. S., & Lee, K. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01395.x · Cited by 122
Improved glucose tolerance in mice receiving intraperitoneal transplantation of normal fat tissue
Konrad, D., Rudich, A., & Schoenle, E. J. (2007) · Diabetologia · doi:10.1007/s00125-007-0596-1 · Cited by 102
Antiobesity action of ɛ-polylysine, a potent inhibitor of pancreatic lipase
Tsujita, T., Takaichi, H., Takaku, T., Aoyama, S., & Hiraki, J. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600168-jlr200 · Cited by 97
Effect of weight loss on regional body fat distribution in premenopausal women
Zamboni, M. M., Armellini, F., Turcato, E., Todesco, T., Bissoli, L., Bergamo-Andreis, I., & Bosello, O. (1993) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/58.1.29 · Cited by 72
Hong, M. H., Kim, M. H., Chang, H. J., Kim, N. H., Shin, B. A., Ahn, B. W., & Jung, Y. D. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.02.024 · Cited by 56
Cited by
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Impact of Dietary Polyphenols on Carbohydrate Metabolism
Hanhineva, K., Törrönen, R., Bondia-Pons, I., Pekkinen, J., Kolehmainen, M., Mykkänen, H., & Poutanen, K. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11041365 · Cited by 1,157
Novel insights of dietary polyphenols and obesity
Wang, S., Moustaid-Moussa, N., Chen, L., Mo, H., Shastri, A., Su, R., Bapat, P., Kwun, I., & Shen, C.-L. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.09.001 · Cited by 896
Molecular Regulation of Adipogenesis and Potential Anti-Adipogenic Bioactive Molecules
Moseti, D., Regassa, A., & Kim, W.-K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010124 · Cited by 736
Anti-inflammatory activity of natural dietary flavonoids
Pan, M.-H., Lai, C.-S., & Ho, C.-T. (2010) · Food & Function · doi:10.1039/c0fo00103a · Cited by 605
Metadata
- Authors
- Bose, M., Lambert, J. D., Ju, J., Reuhl, K. R., Shapses, S. A., & Yang, C. S.
- Venue
- The Journal of Nutrition
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 138
- Issue
- 9
- Pages
- 1677-1683
- ISSN
- 0022-3166 (ISSN-L)
- OpenAlex
- W2130213180
- Cited by
- 613
- References
- 34
- FWCI
- 19.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.